Another study found that ATM inhibition or loss of FANCD2 conferred a reduction in HRR and RAD51 foci formation in lung cancer [26], which is consistent with our finding that complete ATM loss in NGP cells impaired HRR through the downregulation of FANCD2 and RAD51 expression. The gene discussed is FANCD2; the disease is lung cancer.